Hugh Cole Insider Profile
4 Followers
Hugh Cole, former SVP, Chief Business Officer at Ariad, holds 0.00 shares in Ariad (Ticker: ~ARIA), holds ― shares in Astria Therapeutics (Ticker: ATXS), holds 110.08K shares in Jounce Therapeutics (Ticker: JNCE).
Hugh Cole's Trading History
| JNCEJounce Therapeutics | Jan 11, 2023 | ― | Informative Sell | 18.48K | $206.95K | |
| ~ARIAAriad | Feb 16, 2017 | ― | Uninformative Sell | ― | $0.00 | |
| ATXSAstria Therapeutics | ― | ― | ― | ― |
You May Also Like
Hugh Cole insider profile FAQ
What is the percentage of profitable transactions made by Hugh Cole?
The percentage of profitable transactions made by Hugh Cole is 50%.
What is the average return per transaction made by Hugh Cole?
The average return per transaction made by Hugh Cole is 3.10%.
What stocks does Hugh Cole hold?
Hugh Cole holds: ~ARIA, ATXS, JNCE stocks.
What was Hugh Cole's most profitable transaction?
Hugh Cole’s most profitable transaction was an Informative Sell of JNCE stock on January 11, 2022. The return on the trade was 80.90%.
What is Hugh Cole's role in Ariad?
Hugh Cole's role in Ariad is SVP, Chief Business Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
